Assyro AI

FDA Orange Book · active-ingredient family

Vecuronium bromide

Vecuronium bromide is approved as 1 brand and 12 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:NORCURON · NDA 018776

1

Brand (NDA)

12

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
NORCURONRLD×2ORGANON USA INCNDA 018776Apr 30, 1984

Generic (ANDA) products (12)

ProductApplicantApplicationTEApproved
VECURONIUM BROMIDE×2HIKMAANDA 203725APJul 30, 2019
VECURONIUM BROMIDE×2EUGIA PHARMAANDA 206670APDec 20, 2018
VECURONIUM BROMIDE×2GLANDANDA 205390APMay 26, 2016
VECURONIUM BROMIDE×2MYLAN LABS LTDANDA 090243APMay 11, 2010
VECURONIUM BROMIDE×2SUN PHARMANDA 079001APJun 17, 2009
VECURONIUM BROMIDE×2SAGENT PHARMS INCANDA 078274APDec 29, 2008
VECURONIUM BROMIDEHOSPIRAANDA 075558Sep 11, 2001
VECURONIUM BROMIDE×2HIKMAANDA 075549APJun 13, 2000
VECURONIUM BROMIDE×2HOSPIRAANDA 075164APOct 21, 1999
VECURONIUM BROMIDE×2MEITHEALANDA 074688APAug 25, 1999
VECURONIUM BROMIDE×2HIKMAANDA 075218Aug 23, 1999
VECURONIUM BROMIDE×2WATSON LABSANDA 074334Aug 31, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Vecuronium bromide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.